Results 81 to 90 of about 2,546 (213)

Bisfosfonato e implantologia

open access: yes, 2023
A implantologia é um tratamento recomendado em pacientes edêntulos. O seu sucesso baseia-se na estabilidade do implante associada a uma boa osteointegração, que pode ser alterada por vários fatores, nomeadamente a toma de bisfosfonatos. Os bisfosfonatos são fármacos, que diminuem a atividade osteoclástica que têm sido utilizados favoravelmente ...
openaire   +1 more source

Atención Podológica en el Síndrome de Dolor Regional Complejo I. Revisión bibliográfica [PDF]

open access: yes, 2017
Treball Final de Grau de Podologia, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, curs: 2016-2017, Tutor: Rafael Cuevas GómezEl síndrome de dolor regional complejo (SDRC) es un proceso doloroso, clasificado en: tipo I sin ...
Martínez Moya, Iván
core  

Osteonecrosis of the jaws in patients treated with bisphosphonates [PDF]

open access: yes, 2012
The literature describes an increasing presence of bisphosphonate-induced osteonecrosis of the jaws (ONJ), characterized by the exposure for over 8 weeks of necrotic bone in the maxillofacial region, after bisphosphonate therapy, in the absence of ...
Ata-Ali Mahmud, Fadi   +3 more
core   +1 more source

Parathyroid hormone for the treatment of osteoporosis: from controversy to reality [PDF]

open access: yes, 2002
The evolution of the idea of the potential use of parathyroid hormone in the treatment of osteoporosis was a long one. It was also an example of how the concepts in medicine can take a long time to change, and the change is mainly dependant on the ...
Vieira, José Gilberto H.
core   +4 more sources

Severe osteonecrosis of the jaws in a compromised patient subjected to bisphosphonate therapy

open access: yesRevista Cubana de Estomatología, 2014
Bisphosphonate-related osteonecrosis of the jaws is characterized by alveolar bone exposure, especially after mucosal trauma or after surgical procedures, in patients who have previously received or who are currently receiving bisphosphonates without a ...
Juliana Dreyer Menezes   +4 more
doaj  

Campaña de mercadeo social para la Fundación Ecuatoriana de Osteogénesis Imperfecta "Protege el Cristal" [PDF]

open access: yes, 2012
La Fundación Ecuatoriana de Osteogénesis Imperfecta (FEOI), es el único Organismo No Gubernamental (ONG) en nuestro país que ayuda a las personas afectadas con ésta enfermedad.
Corrales López, Marco Andrés   +1 more
core  

¿Bifosfonato o Bisfosfonato?

open access: yesActa Médica Colombiana
Uso correcto del término ...
openaire   +1 more source

Carcinoma de paratiróide: características clínicas e anátomo-patológicas de cinco casos [PDF]

open access: yes, 2001
Parathyroid carcinoma is a rare disease, with about 535 cases reported in the literature until now. In this paper, we reviewed 5 cases of parathyroid carcinoma followed at Universidade Federal de São Paulo (UNIFESP) from 1983 to 1998, and discuss aspects
Abrahão, Márcio   +8 more
core   +4 more sources

Efeito Antiproliferativo do Zoledronato em Linhagens Celulares Tumorais

open access: yesRevista Brasileira de Cancerologia, 2018
Introdução: Bisfosfonatos são fármacos utilizados para o tratamento de enfermidades ósseas, como a osteoporose e metástases ósseas, em razão do seu mecanismo de ação, que consiste na diminuição do processo de reabsorção do osso.
Patricia Maria Wiziack Zago   +6 more
doaj   +1 more source

β-arrestin/connexin 43 complex anchors ERKs outside the nucleus: a pre-requisite for bisphosphonate anti-apoptotic effect mediated by CX43/ERK in osteocytes [PDF]

open access: yes, 2016
Bisphosphonates (BPs) anti-fracture ef cacy may be due in part to inhibition of osteocyte apoptosis. This effect requires opening of con- nexin (Cx) 43 hemichannels and phosphoryla- tion of the extracellular signal regulated kinases (ERKs).
Bellido, Teresita   +2 more
core  

Home - About - Disclaimer - Privacy